Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Xencor Inc (XNCR)  
$20.36 0.98 (4.59%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 66,383,000
Market Cap: 1.35(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $16.53 - $28.72
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 2
Insider 3/6 Months : 2.6
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. Co. is developing a portfolio of clinical-stage XmAb® drug candidates from its protein engineering technology platforms. Co.'s XmAb bispecific Fc drug candidates include: Vudalimab (XmAb717), which is a bispecific antibody that targets PD-1 and CTLA-4 and for patients with metastatic castration-resistant prostate cancer and other solid tumor types; and Plamotamab, which is a bispecific antibody that targets CD20, an antigen on B-cell tumors, and CD3, an activating receptor on T cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 53 53 53
Total Buy Value $0 $1,013 $1,013 $1,013
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 1
Total Shares Sold 51,988 151,096 184,593 219,438
Total Sell Value $1,215,592 $3,206,005 $4,083,291 $5,152,397
Total People Sold 6 6 6 7
Total Sell Transactions 10 12 13 28
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 312
  Page 13 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Desjarlais John R Sr. V.P., Research & CSO   •       –      –    2015-03-17 4 D $15.35 $153,518 D/D (10,000) 18,183     -
   Dahiyat Bassil I President and CEO   •       •      –    2015-03-13 4 D $14.44 $1,070,552 D/D (74,160) 167,420     -
   Dahiyat Bassil I President and CEO   •       •      –    2015-03-12 4 D $14.87 $339,724 D/D (22,840) 241,580     -
   Dahiyat Bassil I President and CEO   •       •      –    2015-03-12 4 OE $0.59 $147,449 D/D 249,914 264,420     -
   Stafford John S Iii Director   –       •       •   2015-03-11 4 GA $0.00 $0 D/D 94,000 120,000     -
   Ronin Trading, Llc 10% Owner   –       –       •   2015-03-11 4 GD $0.00 $0 D/D 94,000 7,487,240     -
   Desjarlais John R Sr. V.P., Research & CSO   •       –      –    2015-01-30 4 OE $0.59 $15,513 D/D 26,294 28,183     -
   Stafford John S Iii Director   –       •       •   2014-08-12 4 GD $0.00 $0 D/D 1,638 26,000     -
   Stafford John S Iii Director   –       •       •   2014-08-11 4 S $9.37 $1,161,880 D/D (124,000) 27,638     -
   Stafford John S Iii Director   –       •       •   2014-06-18 4 GD $0.00 $0 D/D 275,000 151,638     -
   Ronin Trading, Llc 10% Owner   –       –       •   2014-06-12 3 IO $0.00 $0 D/D 0 7,581,240     -
   Stafford John S Iii Director   –       •       •   2014-06-12 4 GD $0.00 $0 D/D 7,306,240 426,638     -
  312 Records found
  Previous  10  11  12  13    
  Page 13 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us